New pill targets Hard-to-Treat lymphoma in first human trial
Disease control
Recruiting now
This early-stage trial tests an experimental drug called ARV-393 in 255 adults with advanced non-Hodgkin's lymphoma that has come back or not responded to other treatments. The drug is taken as a pill and works by breaking down a protein that helps lymphoma grow. The main goals a…
Phase: PHASE1 • Sponsor: Arvinas Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC